Literature DB >> 29691329

Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Joshua Barry1, Garnik Akopian1, Carlos Cepeda1, Michael S Levine2.   

Abstract

The present study examined synaptic communication between direct and indirect output pathway striatal medium-sized spiny neurons (MSNs) and their target structures, the substantia nigra pars reticulata (SNr) and the external globus pallidus (GPe) in two mouse models of Huntington's disease (HD). Cre recombination, optogenetics, and whole-cell patch-clamp recordings were used to determine alterations in intrinsic and synaptic properties of SNr and GPe neurons from both male and female symptomatic R6/2 (>60 d) and presymptomatic (2 months) or symptomatic (10-12 months) YAC128 mice. Cell membrane capacitance was decreased, whereas input resistance was increased in SNr neurons from R6/2, but not YAC128 mice. The amplitude of GABAergic responses evoked by optogenetic stimulation of direct pathway terminals was reduced in SNr neurons of symptomatic mice of both models. A decrease in spontaneous GABA synaptic activity, in particular large-amplitude events, in SNr neurons also was observed. Passive membrane properties of GPe neurons were not different between R6/2 or YAC128 mice and their control littermates. Similarly, the amplitude of GABA responses evoked by activation of indirect pathway MSN terminals and the frequency of spontaneous GABA synaptic activity were similar in HD and control animals. In contrast, the decay time of the evoked GABA response was significantly longer in cells from HD mice. Interestingly, activation of indirect pathway MSNs within the striatum evoked larger-amplitude responses in direct pathway MSNs. Together, these results demonstrate differential alterations in responses evoked by direct and indirect pathway terminals in SNr and GPe leading to striatal output imbalance and motor dysfunction.SIGNIFICANCE STATEMENT Previous work on Huntington's disease (HD) focused on striatal medium-sized spiny neurons (MSNs) almost exclusively. Little is known about the effects that alterations in the striatum have on output structures of the direct and indirect pathways, the substantia nigra pars reticulata (SNr) and the external segment of the globus pallidus (GPe), respectively. We combined electrophysiological and optogenetic methods to examine responses evoked by selective activation of terminals of direct and indirect pathway MSNs in SNr and GPe neurons in two mouse models of HD. We show a differential disruption of synaptic communication between the direct and indirect output pathways of the striatum with their target regions leading to an imbalance of striatal output, which will contribute to motor dysfunction.
Copyright © 2018 the authors 0270-6474/18/384678-17$15.00/0.

Entities:  

Keywords:  Huntington's disease; electrophysiology; external globus pallidus; optogenetics; substantia nigra; synaptic activity

Mesh:

Substances:

Year:  2018        PMID: 29691329      PMCID: PMC5956986          DOI: 10.1523/JNEUROSCI.0434-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Authors:  G J Klapstein; R S Fisher; H Zanjani; C Cepeda; E S Jokel; M F Chesselet; M S Levine
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

2.  Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs.

Authors:  Shiaoching Gong; Martin Doughty; Carroll R Harbaugh; Alexander Cummins; Mary E Hatten; Nathaniel Heintz; Charles R Gerfen
Journal:  J Neurosci       Date:  2007-09-12       Impact factor: 6.167

3.  Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.

Authors:  G A Laforet; E Sapp; K Chase; C McIntyre; F M Boyce; M Campbell; B A Cadigan; L Warzecki; D A Tagle; P H Reddy; C Cepeda; C R Calvert; E S Jokel; G J Klapstein; M A Ariano; M S Levine; M DiFiglia; N Aronin
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

4.  Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.

Authors:  Carlos Cepeda; Laurie Galvan; Sandra M Holley; Shilpa P Rao; Véronique M André; Elian P Botelho; Jane Y Chen; Joseph B Watson; Karl Deisseroth; Michael S Levine
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

5.  Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.

Authors:  P F Behrens; P Franz; B Woodman; K S Lindenberg; G B Landwehrmeyer
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

6.  Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington's disease.

Authors:  Garnik Akopian; Joshua Barry; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci Res       Date:  2016-09-12       Impact factor: 4.164

7.  Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.

Authors:  R L Albin; A Reiner; K D Anderson; L S Dure; B Handelin; R Balfour; W O Whetsell; J B Penney; A B Young
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

8.  Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.

Authors:  K L Allen; H J Waldvogel; M Glass; R L M Faull
Journal:  J Chem Neuroanat       Date:  2009-02-21       Impact factor: 3.052

9.  Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.

Authors:  Elizabeth J Slow; Jeremy van Raamsdonk; Daniel Rogers; Sarah H Coleman; Rona K Graham; Yu Deng; Rosemary Oh; Nagat Bissada; Sazzad M Hossain; Yu-Zhou Yang; Xiao-Jiang Li; Elizabeth M Simpson; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

10.  Early GABAergic transmission defects in the external globus pallidus and rest/activity rhythm alteration in a mouse model of Huntington's disease.

Authors:  Zhuowei Du; Marine Chazalon; Emma Bestaven; Thierry Leste-Lasserre; Jérôme Baufreton; Jean-René Cazalets; Yoon H Cho; Maurice Garret
Journal:  Neuroscience       Date:  2016-05-20       Impact factor: 3.590

View more
  11 in total

Review 1.  New era of optogenetics: from the central to peripheral nervous system.

Authors:  Xiang Xu; Thomas Mee; Xiaofeng Jia
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-02-18       Impact factor: 8.250

2.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 3.  Cholinergic modulation of spatial learning, memory and navigation.

Authors:  Nicola Solari; Balázs Hangya
Journal:  Eur J Neurosci       Date:  2018-08-19       Impact factor: 3.386

4.  Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.

Authors:  Joseph W Goodliffe; Hanbing Song; Anastasia Rubakovic; Wayne Chang; Maria Medalla; Christina M Weaver; Jennifer I Luebke
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

5.  Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.

Authors:  Zheng Wu; Matthew Parry; Xiao-Yi Hou; Min-Hui Liu; Hui Wang; Rachel Cain; Zi-Fei Pei; Yu-Chen Chen; Zi-Yuan Guo; Sambangi Abhijeet; Gong Chen
Journal:  Nat Commun       Date:  2020-02-27       Impact factor: 14.919

Review 6.  Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease.

Authors:  Melissa Serranilla; Melanie A Woodin
Journal:  Front Cell Neurosci       Date:  2022-01-14       Impact factor: 5.505

Review 7.  Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.

Authors:  Julia Kaye; Terry Reisine; Steve Finkbeiner
Journal:  Fac Rev       Date:  2021-10-21

8.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

9.  Mechanisms underlying the enhancement of γ-aminobutyric acid responses in the external globus pallidus of R6/2 Huntington's disease model mice.

Authors:  Joshua Barry; Theodore A Sarafian; Joseph B Watson; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci Res       Date:  2020-08-27       Impact factor: 4.433

10.  Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.

Authors:  Justin L Shobe; Elissa J Donzis; Kwang Lee; Samiksha Chopra; Sotiris C Masmanidis; Carlos Cepeda; Michael S Levine
Journal:  Neurobiol Dis       Date:  2021-07-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.